Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Burkitt Lymphoma × Cholestanetriol 26-Monooxygenase × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 4 fludarabine 3 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 fiu protein, E coli 1 Vincristine 1 Surveys and Questionnaires 1 Sugars 1 Sirolimus 1 Pemetrexed 1 Methotrexate 1 Melphalan 1 Loratadine 1 Doxorubicin 1 Cholestanetriol 26-Monooxygenase 1 CVAD protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Hebei Senlang Biotechnology Inc., Ltd.

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡